Description Trametinib, marketed under the brand name MEKINIST, It is an prescription medication that has been approved trametinib (brand name Mekinist) on May 29, 2013. Trametinib is a kinase inhibitor that treats a variety of cancers with BRAF mutations, including: Melanoma, Metastatic non-small cell lung cancer, Thyroid cancer, Solid tumors, and Low-grade glioma. What is MEKINIST (trametinib) ? MEKINIST is a kinase inhibitor indicated as a single agent and in combination with dabrafenib for the treatment of patients with unresectable or metastatic melanoma with BRAF V600E or V600K mutations as detected by an FDA-approved test. The use in combination is based on the demonstration of durable response rate. Improvement in disease-related symptoms or overall survival has not been demonstrated for MEKINIST in combination with dabrafenib How to order approved “MEKINIST (trametinib) for tablets” Medicine? MEKINIST (Trametinib) tablets is a prescription medicine, it can be accessed through the Named Patient Program (NPP) for treatment in the following city of India – Bengaluru, Delhi, Chennai, Hyderabad, Mumbai, Pune, Kolkata, Ahmedabad, Gurgaon. To inquire about the cost price of purchasing MEKINIST and arranging delivery to your location, please get in touch with Mr. Rakesh at 91 9910645395 or send an enquiry to info@cancermedicinesnetwork. We assure you of the quality of the product and guarantee delivery in accordance with your specific requirements.
